Neurology
Service
Hospital Miguel Servet
Zaragoza, EspañaPublications in collaboration with researchers from Hospital Miguel Servet (38)
2024
-
Assessing illness-related uncertainty in relapsing-remitting multiple sclerosis: A psychometric analysis of the Mishel Uncertainty of Illness Scale
Multiple Sclerosis Journal - Experimental, Translational and Clinical, Vol. 10, Núm. 2
-
Clinical characteristics and impact on patient-reported outcomes and quality of life of people with ambulatory secondary progressive multiple sclerosis: Discover study
Multiple Sclerosis and Related Disorders, Vol. 90
-
Decisional Conflict Regarding Disease-Modifying Treatment Choices Among Patients with Mid-Stage Relapsing-Remitting Multiple Sclerosis
Patient Preference and Adherence , Vol. 18, pp. 1163-1171
-
Incidence and outcoMes of MInor stroke and high-risk traNsient ischEmic attack in NordicTus. IMMINENT study
Neurologia
-
Investigating the 2023 MOGAD Criteria in Children and Adults With MOG-Antibody Positivity Within and Outside Attacks
Neurology, Vol. 103, Núm. 6
-
Perceived illness-related uncertainty among patients with mid-stage relapsing-remitting multiple sclerosis
Multiple Sclerosis and Related Disorders, Vol. 91
2023
-
Epidemiology of ataxia and hereditary spastic paraplegia in Spain: a cross-sectional study
Neurologia, Vol. 38, Núm. 6, pp. 379-386
-
Exploring the Spectrum of RHOBTB2 Variants Associated with Developmental Encephalopathy 64: A Case Series and Literature Review
Movement Disorders Clinical Practice, Vol. 10, Núm. 11, pp. 1671-1679
-
Hopelessness in Patients with Early-Stage Relapsing-Remitting Multiple Sclerosis
Patient Preference and Adherence, Vol. 17, pp. 1431-1439
-
Seroprevalence of SARS-CoV-2 in Patients with Multiple Sclerosis under Disease-Modifying Therapies: A Multi-Centre Study
Journal of Clinical Medicine, Vol. 12, Núm. 23
2022
-
Consensus on early detection of disease progression in patients with multiple sclerosis
Frontiers in Neurology, Vol. 13
-
Disease modifying therapy switching in relapsing multiple sclerosis: A Delphi consensus of the demyelinating expert group of the Spanish society of neurology
Multiple Sclerosis and Related Disorders, Vol. 63
-
Expert-Agreed Practical Recommendations on the Use of Cladribine
Neurology and Therapy
2021
-
Alzemon: estudio de seguimiento prospectivo del acetato de eslicarbacepina en monoterapia en pacientes con epilepsia de diagnóstico reciente
Revista de neurologia, Vol. 72, Núm. 8, pp. 263-268
-
Delayed Neurological Improvement After Full Endovascular Reperfusion in Acute Anterior Circulation Ischemic Stroke
Stroke, Vol. 52, Núm. 7, pp. 2210-2217
-
Impact of Mediterranean Diet prior to Stroke on the Prognosis of Patients Undergoing Endovascular Treatment
Cerebrovascular Diseases, Vol. 50, Núm. 3, pp. 303-309
-
Impact of the COVID-19 pandemic on the training of Spanish neurology residents
Neurology Perspectives, Vol. 1, Núm. 2, pp. 124-130
-
Recommendations for vaccination in patients with multiple sclerosis who are eligible for immunosuppressive therapies: Spanish consensus statement
Neurologia, Vol. 36, Núm. 1, pp. 50-60
2020
-
Impact of COVID-19 outbreak in reperfusion therapies of acute ischaemic stroke in northwest Spain
European Journal of Neurology, Vol. 27, Núm. 12, pp. 2491-2498
-
Impact of COVID-19 outbreak on ischemic stroke admissions and in-hospital mortality in North-West Spain
International Journal of Stroke, Vol. 15, Núm. 7, pp. 755-762